Application of accurate mass measurement to urine drug screening

Journal of Analytical Toxicology

Volumn 29, Issue 1, 2005, Pages 34-40

  Ojanperä, Ilkka ^a   Pelander, Anna ^a   Laks, Suvi ^a   Gergov, Merja ^a   Vuori, Erkki ^a   Witt, Matthias ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b BRUKER DALTONIK GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CHLORPROTHIXENE; CHLORPROTHIXENE N OXIDE SULFOXIDE; COTININE; DESIGNER DRUG; DIAZEPAM; DIBENZEPIN; DRUG METABOLITE; FLUOXETINE; HYDROXYCOTININE; HYDROXYPINDOLOL; MIANSERIN; MIRTAZAPINE; NICOTINE; NORCHLORPROTHIXENE; NORDAZEPAM; NORFLUOXETINE; NORMIRTAZAPINE; NOROLANZAPINE; OLANZAPINE; OXAZEPAM; PAROXETINE; PINDOLOL; PROPRANOLOL; TEMAZEPAM; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DATA BASE; DRUG ABUSE; DRUG SCREENING; DRUG URINE LEVEL; FOURIER TRANSFORM MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MASS; STANDARD; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 12344284834     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.1.34     Document Type: Article

References (35)

1. B.A. Goldberger and E.J. Cone. Confirmatory tests for drugs in the workplace by gas chromatography-mass spectrometry. J. Chromatogr. A 674: 73-86 (1994).
2. H.H. Maurer. Screening procedures for simultaneous detection of several drug classes used for high throughput toxicological analyses and doping control. A review. Comb. Chem. High Throughput Screen. 3: 467-480 (2000).
3. W. Weinmann, A. Wiedemann, B. Eppinger, M. Renz, and M. Svoboda. Screening for drugs in serum by electrospray ionization/collision-induced dissociation and library searching. J. Am. Soc. Mass Spectrom. 10: 1028-1037 (1999).
4. N. Venisse, P. Marquet, E. Duchoslav, J.L. Dupuy, and G. Lachâtre. A general unknown screening procedure for drugs and toxic compounds in serum using liquid chromatography-electrospray-single quadrupole mass spectrometry. J. Anal. Toxicol. 27: 7-14 (2003).
5. M. Gergov, I. Ojanperä, and E. Vuori. Simultaneous screening for 238 drugs in blood by liquid chromatography-ionspray tandem mass spectrometry with multiple-reaction monitoring. J. Chromatogr. B 795: 41-53 (2003).
6. W. Weinmann, M. Gergov, and M. Goerner. MS/MS-libraries with triple quadrupole-tandem mass spectrometers for drug identification and drug screening. Analusis 28: 934-941 (2000).
7. B.J. Kimble, R.E. Cox, R.V. McPherron, R.W. Olsen, E. Roitman, F.C. Walls, and A.L. Burlingame. Real-time gas chromatography/high resolution mass spectrometry and its application to the analysis of physiological fluids. J. Chromatogr. Sci. 12: 647-655 (1974).
8. W. Ehrenthal, K. Pfleger, and G. Stübing. The use of exact mass measurement with a GC-MS-instrument in toxicological analysis. Acta Pharmacol. Toxicol. (Copenh.) Suppl. 2 41: 199-211 (1977).
9. J.H.J. Dawson and M. Guilhaus. Orthogonal-acceleration time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 3: 155-159 (1989).
10. O.A. Mirgorodskaya, A.A. Shevchenko, I.V. Chernushevich, A.F. Dodonov, and A.I. Miroshnikov. Electrospray-ionization time-of-flight mass spectrometry in protein chemistry. Anal. Chem. 66: 99-107 (1994).
11. H. Zhang, K. Heinig, and J. Henion. Atmospheric pressure ionization time-of-flight mass spectrometry coupled with fast liquid chromatography for quantitation and accurate mass measurement of five pharmaceutical drugs in human plasma. J. Mass Spectrom. 35: 423-431 (2000).
12. L. Fang, M. Demee, J. Cournoyer, T. Sierra, C. Young, and B. Yan. Parallel high-throughput accurate mass measurement using a nine-channel multiplexed electrospray liquid chromatography ultraviolet time-of-flight mass spectrometry system. Rapid Commun. Mass Spectrom. 17: 1425-1432 (2003).
13. M. Gergov, B. Boucher, I. Ojanperä, and E. Vuori. Toxicological screening of urine for drugs by liquid chromatography/time-of-flight mass spectrometry with automated target library search based on elemental formulas. Rapid Commun. Mass Spectrom. 15: 521-526 (2001).
14. A. Pelander, I. Ojanperä, S. Laks, I. Rasanen, and E. Vuori. Toxicological screening with formula-based metabolite identification by liquid chromatography/time-of-flight mass spectrometry. Anal. Chem. 75: 5710-5718 (2003).
15. A.G. Marshall, C.L. Hendrikson, and G.S. Jackson. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrom. Rev. 17: 1-35 (1998).
16. I.J. Amster. Fourier transform mass spectrometry. J. Mass Spectrom. 31: 1325-1337 (1996).
17. M.E. Belov, M.V. Gorshkov, H.R. Udseth, G.A. Anderson, and R.D. Smith. Zeptomole-sensitivity electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry of proteins. Anal. Chem. 72: 2271-2279 (2000).
18. R.T. McIver, R.L. Hunter, and W.D. Bowers. Coupling a quadrupole mass spectrometer and a Fourier transform mass spectrometer. Int. J. Mass Spectrom. Ion Processes 64: 67-77 (1985).
19. G. Baykut, R. Jertz, and M. Witt. Matrix-assisted laser desorption/ionization Fourier transform ion cyclotron resonance mass spectrometry with pulsed in-source collision gas and in-source accumulation. Rapid Commun. Mass Spectrom. 14: 1238-1247 (2000).
20. G. Baykut, J. Fuchser, M. Witt, G. Weiss, and C. Gostelli. Combined ion source for fast switching between electropsray and matrix-assisted laser desorption/ionization in Fourier transform ion cyclotron resonance mass spectrometry. Rapid Commun. Mass Spectrom. 16: 1631-1641 (2002).
21. R.D. Smith, G.A. Anderson, M.S. Lipton, L. Pasa-Tolic, Y. Shen, T.P. Conrads, T.D. Veenstra, and H.R. Udseth. An accurate mass tag strategy for quantitative and high-throughput proteome measurements. Proteomics 2: 513-523 (2002).
22. Application Note for Extraction of Acidic, Neutral and Basic Drugs from Urine, 1ST 1044A, International Sorbent Technology, Hengoed, U.K., 1997.
23. P. Caravatti and M. Alleman. "The infinity cell:" a new trapped ion cell with radiofrequency covered trapping electrodes for Fourier transform ion cyclotron resonance mass spectrometry. Org. Mass Spectrom. 26: 514-518 (1991).
24. K. Pfleger, H.H. Maurer, and A. Weber. Mass Spectral and CC Data of Drugs, Poisons, Pesticides, Pollutants and Their Metabolites, 2nd ed. VCH, Weinheim, Germany, 1992, pp 423-562.
25. M.T. Cancilla, M.D. Leavell, J. Chow, and J.A. Leary. Mass spectrometry and immobilized enzymes for the screening of inhibitor libraries. Proc. Nat. Acad Sci. 97: 12008-12013 (2000).
26. K.F. Blom. Utility of peak shape analyses in determining unresolved interferences in exact mass measurements at low resolution. J. Am. Soc. Mass Spectrom. 9: 789-798 (1998).
27. M.L. Gross. Accurate masses for structure confirmation. J. Am. Soc. Mass Spectrom. 5: 57 (1994).
28. R.A. de Zeeuw. Recent developments in analytical toxicology: for better or for worse. Toxicol. Lett. 102-103: 103-108 (1998).
29. P. Marquet. Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology? Ther. Drug Monit. 24: 125-133 (2002).
30. I. Rasanen, I. Kontinen, J. Nokua, I. Ojanperä, and E. Vuori. Precise gas chromatography with retention time locking in comprehensive lexicological screening for drugs in blood. J. Chromatogr. B 788: 243-250 (2003).
31. A.L. Kellermann, S.D. Fihn, J.P. Logerfo, and M.K. Copass. Utilization and yield of drug screening in the emergency department. Am. J. Emerg. Med. 6: 14-20 (1988).
32. A. Fabbri, G. Marchesini, A.M. Morselli-Labate, S. Rugged, M. Fallani, R. Melandri, V. Bua, A. Pasquale, and A. Vandelli. Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose. Emerg. Mod. J. 20: 25-28 (2003).
33. R.E. Montague, R.F. Grace, J.H. Lewis, and G.M. Shenfield. Urine drug screens in overdose patients do not contribute to immediate clinical management. Ther. Drug Monit. 23: 47-50 (2001).
34. S. Pohjola-Sintonen, K.T. Kivistö, E. Vuori, O. Lapatto-Reiniluoto, E. Tiula, and P.J. Neuvonen. Identification of drugs ingested in acute poisoning: correlation of patient history with drug analyses. Ther. Drug Monit. 22: 749-752 (2000).
35. D.A. Yurek, D.I. Branch, and M.S. Kuo. Development of a system to evaluate compound identity, purity, and concentration in a single experiment and its application in quality assessment of combinatorial libraries and screening hits. J. Comb. Chem. 4: 138-148 (2002).